Patents Represented by Law Firm Senniger, Powers, Leaviit & Roedel
  • Therapeutic use of hemoglobin in the treatment of blood vessel blockage
    Patent number: 5877146
    Abstract: Administration of low doses of hemoglobin minimizes damage to the myocardium after blockage and significantly reduces reperfusion injury. Hemoglobin exerts a pharmacological effect by increasing perfusion and blocking the molecular events leading to permanent injury following an ischemic episode.
    Type: Grant
    Filed: August 7, 1995
    Date of Patent: March 2, 1999
    Assignee: Baxter International Inc.
    Inventors: Jack E. McKenzie, Kenneth E. Burhop
  • Therapeutic administration of hemoglobin in cardiac arrest
    Patent number: 5733869
    Abstract: Administration of stroma-free crosslinked hemoglobin during standard cardiac pulmonary resuscitation procedures enhances return of spontaneous circulation following electrical defibrillation. The difficulty in restoring spontaneous circulation directly correlates with a generally poor prognosis in cases of cardiac arrest. The therapeutic effect of hemoglobin as an adjunct to conventional treatment may thereby improve survival.
    Type: Grant
    Filed: October 6, 1995
    Date of Patent: March 31, 1998
    Assignee: Baxter International, Inc.
    Inventors: Kenneth E. Burhop, Moses S. S. Chow